Relestat

Relestat Dosage/Direction for Use

epinastine

Manufacturer:

Allergan

Distributor:

DKSH
Full Prescribing Info
Dosage/Direction for Use
Adults: Recommended Dose: Instil 1 drop in each affected eye twice daily, during the symptomatic period.
There is no experience with the use of Relestat for >8 weeks.
If >1 topical ophthalmic medicinal product is being used, the medicinal products should be administered at least 10 min apart.
Elderly: Relestat has not been studied in elderly patients. Post-marketing safety data from the tablet formulation of epinastine HCl (up to 20 mg once daily) indicates that there are no particular safety issues for elderly patients compared with adult patients. As such, no dosage adjustment is considered to be necessary.
Children and Adolescents: Relestat may be used in adolescents (≥3 years) at the same dosage as in adults.
Hepatic Impairment: Relestat has not been studied in patients with hepatic impairment. Post-marketing safety data from the tablet formulation of epinastine HCl (up to 20 mg once daily) indicates that incidence of adverse reactions was higher in this group compared with adult patients without hepatic impairment. The daily dose of a 10-mg epinastine HCl tablet is >100-fold higher than the daily dose following Relestat. In addition, the metabolism of epinastine in humans is minimal (<10%). Therefore, no dosage adjustment is considered to be necessary.
Renal Impairment: Relestat has not been studied in patients with renal impairment. Post-marketing safety data from the tablet formulation of epinastine HCl (up to 20 mg once daily) indicate that there are no particular safety issues for patients with renal impairment. As such, no dosage adjustment is considered to be necessary.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in